---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-003387"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2026-02-06T23:59:59+00:00"
generated_at: "2026-05-16T04:06:39.005199+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision raises $2.18M in private placement, acquires 19.98% stake in FLYTE for $5.25M

## Summary
- Initial closing of private placement yields $2.18M; additional closings could raise up to ~$44.6M total.
- Issues Series C-1 convertible preferred at $1.43/share; conversion price can reset to 80% of market price after stockholder approval.
- Acquires 19.98% of Fly Flyte, Inc. (air-mobility) for $5.25M in Series D convertible preferred, contingent on stockholder approval.
- Existing Series B preferred and warrants repriced to $1.78, generating $400k cash from warrant exercises.
- Proceeds to repay debt, wind down legacy catheter business, and explore going-private or spin-off transactions.

## SEC filing metadata
- accession: 0001437749-26-003387
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2026-02-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/vtak20260206_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-003387
- JSON: https://secwatch.observer/filing/0001437749-26-003387.json
- Plain text: https://secwatch.observer/filing/0001437749-26-003387.txt

## Key facts
- Equity Issuances
  Catheter Precision, Inc. issued 392,608 shares of common stock to certain accredited investors for $1.43 per share.
  - Security: common stock
  - Shares: 392,608 shares
  - Purchaser: certain accredited investors
  - Consideration: $1.43 per share
  source text: Placement Financing”) of an aggregate of (i) 392,608 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a per share purchase price of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm
- Equity Issuances
  Catheter Precision, Inc. issued 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock of preferred stock to certain accredited investors for stated value of $1,000 per share.
  - Security: preferred stock
  - Shares: 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock
  - Purchaser: certain accredited investors
  - Consideration: stated value of $1,000 per share
  source text: of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 1,130,301shares of Common Stock, at an initial conversion price of $1.43 per share (the “Series C-1 Preferred Stock” and, together with
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm
- Governance Changes
  Catheter Precision, Inc.: Filing of Certificate of Designations for Series C-1 Preferred Stock, referenced as a charter amendment under Item 5.03.
  - Change: fiscal year change
  source text: Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm
- Material Agreements
  Catheter Precision, Inc. entered into Financing Purchase Agreement with certain accredited investors valued at $2,177,759.00 (effective 2026-02-06).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: $2,177,759.00
  - Effective: 2026-02-06
  source text: On February 6, 2026, Catheter Precision, Inc. (the “Company”) entered into a securities purchase agreement (the “Financing Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement Financing”) of an aggregate of (i) 392,608 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a per share purchase price of $1.43 (the “Common Shares”) and (ii) 1,616.33 shares newly-designated Series C-1 Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 1,130,301shares of Common Stock, at an initial conversion price of $1.43 per share (the “Series C-1 Preferred Stock” and, together with the Common Shares, the “Initial Securities”), for an aggregate purchase price of $2,177,759.00 with respect to the Initial Securities
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774926003387/0001437749-26-003387-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.